Jefferies Group's RGEN Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 6,156 shares of Repligen Corporation (RGEN) worth $1.01 M, representing 0.01% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in RGEN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 8,247 shares. Largest reduction occurred in Q3 2025, reducing 14,280 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Repligen Corporation (RGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Repligen Corporation (RGEN) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +6,156 | New Buy | 6,156 | $163.86 |
| Q3 2025 | -14,280 | Sold Out | 0 | $0.00 |
| Q2 2025 | +8,247 | Add 136.70% | 14,280 | $124.38 |
| Q1 2025 | +6,033 | New Buy | 6,033 | $127.24 |
| Q4 2024 | -6,888 | Sold Out | 0 | $0.00 |
| Q3 2024 | +1,600 | Add 30.26% | 6,888 | $148.82 |
| Q2 2024 | +3,205 | Add 153.86% | 5,288 | $126.06 |
| Q1 2024 | +2,083 | New Buy | 2,083 | $183.92 |
| Q4 2023 | -5,773 | Sold Out | 0 | $0.00 |
| Q3 2023 | -3,305 | Reduce 36.41% | 5,773 | $159.01 |
| Q2 2023 | +9,078 | New Buy | 9,078 | $141.46 |
Jefferies Group's Repligen Corporation Investment FAQs
Jefferies Group first purchased Repligen Corporation (RGEN) in Q2 2023, acquiring 9,078 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Repligen Corporation (RGEN) for 11 quarters since Q2 2023.
Jefferies Group's largest addition to Repligen Corporation (RGEN) was in Q2 2023, adding 9,078 shares worth $1.28 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 6,156 shares of Repligen Corporation (RGEN), valued at approximately $1.01 M.
As of the Q4 2025 filing, Repligen Corporation (RGEN) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Repligen Corporation (RGEN) was 14,280 shares, as reported at the end of Q2 2025.